These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29913183)

  • 1. Predictive metabolomic signatures of end-stage renal disease: A multivariate analysis of population-based data.
    Silva RE; Baldim JL; Chagas-Paula DA; Soares MG; Lago JHG; Gonçalves RV; Novaes RD
    Biochimie; 2018 Sep; 152():14-30. PubMed ID: 29913183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure.
    Kobayashi T; Matsumura Y; Ozawa T; Yanai H; Iwasawa A; Kamachi T; Fujiwara K; Tanaka N; Kohno M
    Anal Bioanal Chem; 2014 Feb; 406(5):1365-76. PubMed ID: 24232639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
    Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
    PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection.
    Gironès N; Carbajosa S; Guerrero NA; Poveda C; Chillón-Marinas C; Fresno M
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3337. PubMed ID: 25412247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease.
    Posada-Ayala M; Zubiri I; Martin-Lorenzo M; Sanz-Maroto A; Molero D; Gonzalez-Calero L; Fernandez-Fernandez B; de la Cuesta F; Laborde CM; Barderas MG; Ortiz A; Vivanco F; Alvarez-Llamas G
    Kidney Int; 2014 Jan; 85(1):103-11. PubMed ID: 24048377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.
    Velenosi TJ; Hennop A; Feere DA; Tieu A; Kucey AS; Kyriacou P; McCuaig LE; Nevison SE; Kerr MA; Urquhart BL
    Sci Rep; 2016 Mar; 6():22526. PubMed ID: 26932318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data.
    Benito S; Sánchez-Ortega A; Unceta N; Jansen JJ; Postma G; Andrade F; Aldámiz-Echevarria L; Buydens LMC; Goicolea MA; Barrio RJ
    J Pharm Biomed Anal; 2018 Feb; 149():46-56. PubMed ID: 29100030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling.
    Kimura T; Yasuda K; Yamamoto R; Soga T; Rakugi H; Hayashi T; Isaka Y
    Sci Rep; 2016 May; 6():26138. PubMed ID: 27188985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).
    Zhao YY; Cheng XL; Wei F; Bai X; Tan XJ; Lin RC; Mei Q
    J Proteome Res; 2013 Feb; 12(2):692-703. PubMed ID: 23227912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung.
    Wang Z; Ma P; Wang Y; Hou B; Zhou C; Tian H; Li B; Shui G; Yang X; Qiang G; Yin C; Du G
    Sci Rep; 2021 Jul; 11(1):14680. PubMed ID: 34282162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans.
    Zhang ZH; Chen H; Vaziri ND; Mao JR; Zhang L; Bai X; Zhao YY
    J Proteome Res; 2016 Oct; 15(10):3802-3812. PubMed ID: 27636000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.
    Liabeuf S; Barreto DV; Barreto FC; Meert N; Glorieux G; Schepers E; Temmar M; Choukroun G; Vanholder R; Massy ZA;
    Nephrol Dial Transplant; 2010 Apr; 25(4):1183-91. PubMed ID: 19914995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
    Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
    Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine and its metabolites--kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease.
    Pawlak K; Kowalewska A; Mysliwiec M; Pawlak D
    Am J Med Sci; 2009 Oct; 338(4):293-300. PubMed ID: 19745702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases.
    Yau YY; Leong RW; Shin S; Bustamante S; Pickford R; Hejazi L; Campbell B; Wasinger VC
    Discov Med; 2014 Sep; 18(98):113-24. PubMed ID: 25227752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study.
    Boelaert J; Lynen F; Glorieux G; Schepers E; Neirynck N; Vanholder R
    Anal Bioanal Chem; 2017 Mar; 409(8):2201-2211. PubMed ID: 28083662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
    Luan H; Liu LF; Meng N; Tang Z; Chua KK; Chen LL; Song JX; Mok VC; Xie LX; Li M; Cai Z
    J Proteome Res; 2015 Jan; 14(1):467-78. PubMed ID: 25271123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.